School of Medicine and Medical Science, UCD Conway Institute of Biomolecular and Biomedical Sciences, University College Dublin, Dublin 4, Ireland.
Am J Respir Cell Mol Biol. 2010 May;42(5):517-23. doi: 10.1165/rcmb.2009-0101TR. Epub 2009 Jul 2.
Gremlin is an extracellular glycoprotein that was first identified over a decade ago through its important role in embryonic development, in which it acts as an antagonist of bone morphogenetic protein actions. It plays a critical role in the development of normal airways and the pulmonary circulation in the embryo. More recently, considerable evidence has been presented for a role for gremlin in the pathogenesis of lung diseases, particularly pulmonary hypertension and idiopathic pulmonary fibrosis. The purpose of this article is to review this evidence, consider the potential mechanisms and multicellular actions by which gremlin contributes to disease pathogenesis, and suggest future avenues of research.
格莱美琳是一种细胞外糖蛋白,十多年前因其在胚胎发育中的重要作用而首次被发现,在胚胎发育中,它作为骨形态发生蛋白作用的拮抗剂。它在正常气道和肺循环的发育中起着关键作用。最近,有大量证据表明格莱美琳在肺部疾病的发病机制中起作用,特别是肺动脉高压和特发性肺纤维化。本文的目的是回顾这方面的证据,考虑格莱美琳参与疾病发病机制的潜在机制和多细胞作用,并提出未来的研究方向。